Genotype-phenotype Analysis of Paraoxonase 1 in Schizophrenic Patients Treated with Atypical Antipsychotics

OBJECTIVE: Recent studies suggest a possible involvement of low paraoxonase 1 (PON1) enzyme activities in the association between schizophrenia, treatment with atypical antipsychotics and increased cardiovascular (CVD) risk. In the present study, we aimed at investigating the PON1 status in a group...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavăl, Denis, Nemeş, Bogdan, Rusu, Răzvan L., Dronca, Eleonora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810443/
https://www.ncbi.nlm.nih.gov/pubmed/29397664
http://dx.doi.org/10.9758/cpn.2018.16.1.32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810443/
https://www.ncbi.nlm.nih.gov/pubmed/29397664
http://dx.doi.org/10.9758/cpn.2018.16.1.32

Ejemplares similares